Artal Group’s Cytokinetics CYTK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
|
|||||
|
2024
Q2 | $26.8M | Sell |
|
|||||
|
2024
Q1 | $35.5M | Sell |
|
|||||
|
2023
Q4 | $101M | Sell |
|
|||||
|
2023
Q3 | $44.7M | Buy |
|
|||||
|
2023
Q2 | $46.2M | Buy |
|
|||||
|
2023
Q1 | $48.1M | Buy |
|
|||||
|
2022
Q4 | $45.8M | Hold |
|
|||||
|
2022
Q3 | $48.5M | Sell |
|
|||||
|
2022
Q2 | $50.1M | Buy |
|
|||||
|
2022
Q1 | $36.8M | Hold |
|
|||||
|
2021
Q4 | $45.6M | Sell |
|
|||||
|
2021
Q3 | $46.5M | Buy |
|
|||||
|
2021
Q2 | $9.89M | Buy |
|
|||||
|
2021
Q1 | – | Sell |
|
|||||
|
2020
Q4 | $10.4M | Buy |
|